Reuters logo
BRIEF-Yichang Hec Changjiang Pharmaceutical posts HY revenue of RMB662.3 mln
August 18, 2017 / 6:01 AM / a month ago

BRIEF-Yichang Hec Changjiang Pharmaceutical posts HY revenue of RMB662.3 mln

Aug 18 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd

* HY revenue was RMB662.3 million, representing an increase of 19.2 percent

* HY profit & total comprehensive income attributable to equity shareholders of co was RMB301.9 million, up 40.4 percent

* Board recommended an interim dividend of RMB0.40 per share (tax inclusive) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below